Andrew Dreyfus

Insider Reports History

Location
Boston, MA
Signature
/s/ Brian Tessler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Dreyfus:

Company Role Class Num Shares Value Price $ Report Date Ownership
IRONWOOD PHARMACEUTICALS INC Director Class A Common Stock 228,313 $212,331 $0.93 10 Jun 2025 Direct
Alto Neuroscience, Inc. Director Stock Option (right to buy) 15,287 $96,920 $3.17 13 May 2025 Direct

Insider Reports Filed by Andrew Dreyfus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRWD IRONWOOD PHARMACEUTICALS INC 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:26
ANRO Alto Neuroscience, Inc. 13 May 2025 1 $0 4 Director 15 May 2025, 16:16
IRWD IRONWOOD PHARMACEUTICALS INC 18 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:05
ANRO Alto Neuroscience, Inc. 01 Feb 2024 1 $0 4 Director 05 Feb 2024, 16:40
ANRO Alto Neuroscience, Inc. 01 Feb 2024 0 $0 3 Director 01 Feb 2024, 18:53
IRWD IRONWOOD PHARMACEUTICALS INC 20 Jun 2023 1 $0 4 Director 22 Jun 2023, 17:27
IRWD IRONWOOD PHARMACEUTICALS INC 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:05
IRWD IRONWOOD PHARMACEUTICALS INC 15 Dec 2021 1 $0 4 Director 17 Dec 2021, 15:05
IRWD IRONWOOD PHARMACEUTICALS INC 15 Sep 2021 1 $0 4 Director 17 Sep 2021, 16:47
IRWD IRONWOOD PHARMACEUTICALS INC 15 Jun 2021 1 $0 4 Director 16 Jun 2021, 16:31
IRWD IRONWOOD PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 16:07